BioSpace News Archive

X-Chem, Inc. (X-Chem), the global leader in DNA-encoded small molecule library screening and drug discovery, announced today that it has met a key development milestone in its collaboration with Orexia Limited (Orexia), a company focused on developing orexin positive modulators using unique structure based drug design capabilities.

Evotec SE announced that the U.S. Department of Defense awarded its Seattle-based subsidiary, Just - Evotec Biologics, Inc. a contract valued up to $ 18.2 m to develop and manufacture monoclonal antibodies for treatment and/or prevention of COVID-19.

.Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert in immunotherapy showcased the broad potential of BI-1206 in enhancing checkpoint inhibitors in solid cancers in a KOL event hosted by BioInvent on July 21.

European Union regulatory approval in place for IRRAflow Control Unit, Tube Sets, and Single-use Catheters until May 2024

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

-Trial is evaluating the safety and efficacy of farnesoid X receptor agonist TERN-101 in NASH patients -

Eargo, a medical device company on a mission to improve the quality of life of people with hearing loss, announced that CEO Christian Gormsen has won two 2020 Comparably Awards for the categories of “Best CEOs for Diversity” and “Best CEOs for Women.”

United Therapeutics Corporation announced that it will report its second quarter 2020 financial results before the market opens on Wednesday, July 29, 2020.

Transparency Market Research has published a new report titled, ‘Medical Image Analysis Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global biotherapeutics cell line development market was valued at ~US$ 100 Mn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period.